Cristina Ricciardelli
Foggia, 71122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies.
Journal: Biomedicines
Published: August 15, 2022
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis.
Journal: Digestive diseases and sciences
Published: April 30, 2019
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers.
Journal: Annals of gastroenterology
Published: February 13, 2019
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers.
Journal: Medicine
Published: August 26, 2018
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: September 19, 2017
Effectiveness and safety of infliximab biosimilar CT-P13 in treating ulcerative colitis: a real‑life experience in IBD primary centers.
Journal: Minerva gastroenterologica e dietologica
Published: March 16, 2017
Effectiveness of golimumab in inducing remission and clinical response in outpatient ulcerative colitis.
Journal: Clinics and research in hepatology and gastroenterology
Published: March 01, 2016
Letter: effectiveness of golimumab to induce remission in outpatient ulcerative colitis in Italy.
Journal: Alimentary pharmacology & therapeutics
Published: February 05, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026